Understanding the protection level against reinfection and severe disease
With the shift of the SARS-CoV-2 pandemic into the post-vaccine phase, where large proportions of the populations are vaccinated, it becomes more and more important to understand the protection level against reinfection and severe disease to manage the virus on both individual and society level. Serology testing to monitor antibody levels is an important part of this active surveillance of virus behaviour and the protection status of the society.
In this short webinar we introduce the Gentian SARS-CoV-2 Total Antibody Immunoassay that was released March 2022. The high quality and fast-throughput serology assay for automated clinical chemistry platforms will help increase the test capacity for routine antibody testing.
Watch the webinar now:
Pandemic management through antibody testing
Antibody testing as a tool to document protection for individuals and society:
- Long-term surveillance of immunity of the society
- Monitoring of both natural and vaccine-related immune response
- Understand virus behaviour, including virus variations
- Guide educated decisions about herd immunity and vaccination strategies
Contact us for more information
Let us know if you want more information about the assay or want to validate the assay in your laboratory.
Please send us an email to marketing@gentian.com or fill out the form below. Our Product Manager for SARS-CoV-2 Total Antibody Immunoassay will get in touch.
